ALLERGAN USA, INC. for ALLERGAN USA, INC.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 20, 2012 | $470,000 | Replaced |
| 2nd Quarter - Amendment (this page) | Jul 27, 2012 | $510,000 | Yes |
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Telecommunications TEC
Junk Fax regulations and interpretations, and rule promulgations
| Lobbyist | Covered position, as disclosed |
|---|---|
| G THOMAS LONG | — |
| TED PIPER | — |
| ASHLIE VAN METER | — |
Copyright/Patent/Trademark CPT
S. 23, H.R.1249, The America Invents Act S. 27 Preserve Access to Life Saving Medicine Act Patient Protection and Affordable Care Act S. 1882, Fair and Immediate Release of Generic Drug Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| G THOMAS LONG | — |
| TED PIPER | — |
| ASHLIE VAN METER | — |
Health Issues HCR
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
| Lobbyist | Covered position, as disclosed |
|---|---|
| G THOMAS LONG | — |
| TED PIPER | — |
| ASHLIE VAN METER | — |
Budget/Appropriations BUD
Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions Appropriations Agriculture, Rural Development, Food and Drug Administration, and Related Agencies; Fuding of FDA; S3187, HR 5651
| Lobbyist | Covered position, as disclosed |
|---|---|
| G THOMAS LONG | — |
| TED PIPER | — |
| ASHLIE VAN METER | — |
Medicare/Medicaid MMM
Medicare Improvement for Patients and Providers Act of 2008 (P.L. 110-275) Reimbursement policy and coverage issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| G THOMAS LONG | — |
| TED PIPER | — |
| ASHLIE VAN METER | — |
Medical/Disease Research/Clinical Labs MED
Kidney Disease Education governement partnership opportunities for research and development
| Lobbyist | Covered position, as disclosed |
|---|---|
| G THOMAS LONG | — |
| TED PIPER | — |
| ASHLIE VAN METER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.